· 10/29/2003
Asahi Glass Co., Ltd. v. Pentech Pharmaceuticals
Citations
- 289 F. Supp. 2d 986
- 2003 U.S. Dist. LEXIS 19370
- 2003 WL 22462405
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- applying the scope-of-the patent test; “there is no doubt that the patent may well be valid, so that Glaxo cannot be faulted for trying to enforce it.”
- “If any settlement agreement is thus to be classified as involving a forbidden ‘reverse payment’ we shall have no more patent settlements.”
- the competitor could use the provided product to undersell the brand manufacturer
- “The claim of fraud on the patent office fails for the reason just given: if patent 723 was obtained by fraud, it was a fraud aimed at competing manufacturers of drugs, not at the suppliers of those manufacturers, and so the fraud claim cannot be pressed as an antitrust claim.”
Source: CourtListener parenthetical corpus (CC0).
Judges: Posner
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.